Atlas Trials

An Ascending Dose Study of KW-2449 in Acute Leukemias, Myelodysplastic Syndromes, and Chronic Myelogenous Leukemia

Clinical trial NCT00346632 · TERMINATED

Trial details

NCT number
NCT00346632
Sponsor
Kyowa Kirin, Inc.
Status
TERMINATED
Phase
Phase 1
Study type
INTERVENTIONAL
Acute Myelogenous LeukemiaAcute Lymphoblastic LeukemiaMyelodysplastic SyndromesChronic Myelogenous Leukemia
Start date
2006-06-01
Primary completion
2008-04-01
Enrollment
37

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.